Periscope Capital’s Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( CHAQ.WS Stock Holding History

Periscope Capital’s Portfolio CHAQ.WS Stock Details CHAQ.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-32,442	Closed	-$21K	–	1019
2021 Q2	$21K	Sell	32,442 -56,558	-64%	-$40.5K	﹤0.01%	738
2021 Q1	$83K	Sell	89,000 -156,900	-64%	-$174K	﹤0.01%	519
2020 Q4	$243K	Hold	245,900	–	–	0.01%	312
2020 Q3	$177K	Buy	+245,900	New	+$172K	0.01%	248

Periscope Capital's CHAQ.WS Position: Q3 2021 in Review

Periscope Capital sold out of Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( (CHAQ.WS) in Q3 2021, closing a stake of 32,442 shares — an estimated $21K sold.

Periscope Capital first reported a position in CHAQ.WS in Q3 2020 and held it in 4 quarters. The position peaked at $243K in Q4 2020. 0 funds tracked by Wall St. Rank hold CHAQ.WS as of Q3 2021.

Periscope Capital reported no remaining Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( position as of Q3 2021 after selling out during the quarter.
Periscope Capital sold 32,442 Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( shares in Q3 2021, an estimated $21K.
Periscope Capital first reported a position in Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( in Q3 2020 and held it in 4 quarters.
Periscope Capital's Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( position peaked at $243K in Q4 2020.
0 funds tracked by Wall St. Rank held Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( as of Q3 2021.

Based on Periscope Capital's 13F filing for Q3 2021, filed 12 Nov 2021.